COHEN CHARLES J. 4
4 · Xenon Pharmaceuticals Inc. · Filed Oct 24, 2017
Insider Transaction Report
Form 4
COHEN CHARLES J.
VP, Biology
Transactions
- Award
Stock Option (Right to Buy)
2017-10-23+11,000→ 11,000 totalExercise: $3.10Exp: 2027-10-22→ Common Shares (11,000 underlying)
Footnotes (1)
- [F1]Vesting 25% on October 23, 2018, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.